---
figid: PMC7285805__ol-20-01-0455-g01
figlink: pmc/articles/PMC7285805/figure/f2-ol-0-0-11614/
number: F2
caption: Targeting the IL-4/IL-13/STAT6 signaling pathway for cancer therapy. Upon
  cytokine-receptor binding, JAK1, JAK2 or tyrosine kinase 2 are recruited and activated,
  inducing the phosphorylation of STAT6. STAT6 homodimers translocate to the nucleus
  and bind DNA sequences at genes involved in apoptosis, proliferation and the immune
  response. Various drug targets have been evaluated to block IL-4, IL-4R, IL-13Rα1
  or STAT6. Points of potential therapeutic inhibition of the pathway are indicated.
  STAT6, signal transducer and activator of transcription 6; IL-R, interleukin receptor;
  JAK, Janus kinase; miR, microRNA; siRNA, small interfering RNA; γc, γ chain.
pmcid: PMC7285805
papertitle: Signal transducer and activator of transcription 6 as a target in colon
  cancer therapy.
reftext: Yael Delgado-Ramirez, et al. Oncol Lett. 2020 Jul;20(1):455-464.
pmc_ranked_result_index: '735'
pathway_score: 0.9539483
filename: ol-20-01-0455-g01.jpg
figtitle: Targeting the IL-4/IL-13/STAT6 signaling pathway for cancer therapy
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7285805__ol-20-01-0455-g01.html
  '@type': Dataset
  description: Targeting the IL-4/IL-13/STAT6 signaling pathway for cancer therapy.
    Upon cytokine-receptor binding, JAK1, JAK2 or tyrosine kinase 2 are recruited
    and activated, inducing the phosphorylation of STAT6. STAT6 homodimers translocate
    to the nucleus and bind DNA sequences at genes involved in apoptosis, proliferation
    and the immune response. Various drug targets have been evaluated to block IL-4,
    IL-4R, IL-13Rα1 or STAT6. Points of potential therapeutic inhibition of the pathway
    are indicated. STAT6, signal transducer and activator of transcription 6; IL-R,
    interleukin receptor; JAK, Janus kinase; miR, microRNA; siRNA, small interfering
    RNA; γc, γ chain.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL4
  - IL13RA2
  - IL13
  - IL13RA1
  - TYK2
  - JAK1
  - JAK3
  - JAK2
  - STAT6
  - Tofacitinib
  - Ruxolitinib
  - Regorafenib
  - Pacritinib
  - Propofol
genes:
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL13Ra2
  symbol: IL13RA2
  source: hgnc_symbol
  hgnc_symbol: IL13RA2
  entrez: '3598'
- word: IL-13
  symbol: IL-13
  source: hgnc_alias_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: IL-13
  symbol: IL-13
  source: hgnc_alias_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: IL-13RA1
  symbol: IL13RA1
  source: hgnc_symbol
  hgnc_symbol: IL13RA1
  entrez: '3597'
- word: IL-13Ra2
  symbol: IL13RA2
  source: hgnc_symbol
  hgnc_symbol: IL13RA2
  entrez: '3598'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
chemicals:
- word: Tofacitinib
  source: MESH
  identifier: C479163
- word: Ruxolitinib
  source: MESH
  identifier: C540383
- word: Regorafenib
  source: MESH
  identifier: C559147
- word: Pacritinib
  source: MESH
  identifier: C561234
- word: Propofol
  source: MESH
  identifier: D015742
diseases: []
figid_alias: PMC7285805__F2
redirect_from: /figures/PMC7285805__F2
figtype: Figure
---
